F. Cetani, E. Pardi, C. Marcocci, Update on parathyroid carcinoma. J. Endocrinol. Invest. 39(6), 595–606 (2016)

Article  CAS  PubMed  Google Scholar 

S. Xue, H. Chen, C. Lv et al. Preoperative diagnosis and prognosis in 40 Parathyroid Carcinoma Patients. Clin. Endocrinol. 85(1), 29–36 (2016)

Article  Google Scholar 

P. Wang, S. Xue, S. Wang et al. Clinical characteristics and treatment outcomes of parathyroid carcinoma: a retrospective review of 234 cases. Oncol. Lett. 14(6), 7276–7282 (2017)

PubMed  PubMed Central  Google Scholar 

B. Wei, T. Zhao, H. Shen et al. Extended En bloc reoperation for recurrent or persistent parathyroid carcinoma: analysis of 31 cases in a single institute experience. Ann. Surg. Oncol. 29(2), 1208–1215 (2022)

Article  PubMed  Google Scholar 

E.M. Ryhänen, H. Leijon, S. Metso et al. A nationwide study on parathyroid carcinoma. Acta Oncol. 56(7), 991–1003 (2017)

Article  PubMed  Google Scholar 

J.C.M. Wan, C. Massie, J. Garcia-Corbacho et al. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat. Rev. Cancer 17(4), 223–238 (2017)

Article  CAS  PubMed  Google Scholar 

J. Kaiser, ‘Liquid biopsy’ for cancer promises early detection. Science. 359(6373), 259 (2018)

Article  CAS  PubMed  Google Scholar 

A. Bardelli, K. Pantel, Liquid biopsies, what we do not know (Yet). Cancer Cell 31(2), 172–179 (2017)

Article  CAS  PubMed  Google Scholar 

Y. Sun, T.A. Haglund, A.J. Rogers et al. Review: microfluidics technologies for blood-based cancer liquid biopsies. Anal. Chim. Acta 1012, 10–29 (2018)

Article  CAS  PubMed  Google Scholar 

X. Qiu, H. Zhang, Y. Zhao et al. Application of circulating genetically abnormal cells in the diagnosis of early-stage lung cancer. J Cancer Res. Clin. Oncol. 148(3), 685–695 (2022)

Article  CAS  PubMed  Google Scholar 

M. Fontanilles, A. Duran-Pena, A. Idbaih, Liquid biopsy in primary brain tumors: looking for stardust! Curr. Neurol. Neurosci. Rep. 18(3), 13 (2018)

Article  PubMed  Google Scholar 

J.F. Swennenhuis, G. van Dalum, L.L. Zeune et al. Improving the CellSearch(R) system. Expert Rev. Mol. Diagn. 16(12), 1291–1305 (2016)

Article  CAS  PubMed  Google Scholar 

T. Szabo Yamashita, A.S. Shirali, S. Meas et al. Is there a role for liquid biopsy in the surveillance of parathyroid carcinoma? Surgery. 175(1), 193–198 (2024)

Article  PubMed  Google Scholar 

R. Zhu, Z. Wang, Y. Hu, Prognostic role of parafibromin staining and CDC73 mutation in patients with parathyroid carcinoma: A systematic review and meta-analysis based on individual patient data. Clin. Endocrinol. 92(4), 295–302 (2020)

Article  CAS  Google Scholar 

Y. Li, J. Zhang, R.A. Poorni et al. Genotype of CDC73 germline mutation determines risk of parathyroid cancer. Endocr. Relat. Cancer 27(9), 483–494 (2020)

Article  CAS  PubMed  PubMed Central  Google Scholar 

Y. Li, X. Zhang, J. Gong et al. Aneuploidy of chromosome 8 in circulating tumor cells correlates with prognosis in patients with advanced gastric cancer. Chin. J. Cancer Res. 28(6), 579–588 (2016)

Article  CAS  PubMed  PubMed Central  Google Scholar 

R.L. Katz, T.M. Zaidi, D. Pujara et al. Identification of circulating tumor cells using 4-color fluorescence in situ hybridization: Validation of a noninvasive aid for ruling out lung cancer in patients with low-dose computed tomography-detected lung nodules. Cancer Cytopathol. 128(8), 553–562 (2020)

Article  CAS  PubMed  Google Scholar 

Y. Chen, Z. Yang, Y. Wang et al. Karyotyping of circulating tumor cells for predicting chemotherapeutic sensitivity and efficacy in patients with esophageal cancer. BMC Cancer 19(1), 651 (2020)

Article  Google Scholar 

J. Liu, C. Ma, X. Li et al. Circulating tumor cells correlating with Ki-67 predicts the prognosis of bladder cancer patients. Int. Urol. Nephrol. 55(2), 309–318 (2023)

Article  CAS  PubMed  Google Scholar 

Y. Xu, T. Qin, J. Li et al. Detection of circulating tumor cells using negative enrichment immunofluorescence and an in situ hybridization system in pancreatic cancer. Int. J. Molecual Sci. 18(4), 622 (2017)

Article  Google Scholar 

L. Wang, Y. Li, J. Xu et al. Quantified postsurgical small cell size CTCs and EpCAM(+) circulating tumor stem cells with cytogenetic abnormalities in hepatocellular carcinoma patients determine cancer relapse. Cancer Lett. 412, 99–107 (2018)

Article  CAS  PubMed  Google Scholar 

M. Ye, X. Zheng, X. Ye et al. Circulating genetically abnormal cells add non-invasive diagnosis value to discriminate lung cancer in patients with pulmonary nodules ≤10 mm. Front. Oncol. 11, 638223 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

P.P. Lin, Aneuploid CTC and CEC. Diagnostics 8(2), 26 (2018)

Article  PubMed  PubMed Central  Google Scholar 

W. Wu, Z. Zhang, X.H. Gao et al. Clinical significance of detecting circulating tumor cells in colorectal cancer using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH). Oncotarget. 8(13), 21639–21649 (2017)

Article  PubMed  PubMed Central  Google Scholar 

Q. Fan, S. Wei, L. Yang et al. The emerging role of exosome-derived non-coding RNAs in cancer biology. Cancer Lett. 414, 107–115 (2018)

Article  CAS  PubMed  Google Scholar 

M.P. Davies, T.W. John Evans, F. Tahir et al. Parathyroid cancer: a systematic review of diagnostic biomarkers. Surgeon 19(6), e536–e548 (2021)

Article  PubMed  Google Scholar 

J. Wang, Q. Wang, T. Zhao et al. Expression profile of serum-related exosomal miRNAs from parathyroid tumor. Endocrine. 72(1), 239–248 (2021)

Article  CAS  PubMed  Google Scholar 

J. Krupinova, N. Mokrysheva, V. Petrov et al. Serum circulating miRNA-342-3p as a potential diagnostic biomarker in parathyroid carcinomas: a pilot study. Endocrinol. Diabetes Metab. 4(4), e00284 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

W.-R. Liu, B. Zhang, C. Chen et al. Detection of circulating genetically abnormal cells in peripheral blood for early diagnosis of non-small cell lung cancer. Thorac. Cancer 11(11), 3234–3242 (2020)

Article  CAS  PubMed  PubMed Central  Google Scholar 

M. Feng, X. Ye, B. Chen et al. Detection of circulating genetically abnormal cells using 4-color fluorescence in situ hybridization for the early detection of lung cancer. J. Cancer Res. Clin. Oncol. 147(8), 2397–2405 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar